Increasing peptide complexity, broader portfolio diversity and rapidly changing volume requirements are placing growing constraints on conventional peptide manufacturing models. At the same time, ...
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results